Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,255 | 31,198 | 25,043 | -97,217 | -76,298 |
| Depreciation Amortization | 872 | 613 | 311 | 1,530 | 1,174 |
| Accounts payable and accrued liabilities | 41,671 | 41,979 | -970 | 6,896 | 5,815 |
| Other Working Capital | 37,845 | 34,065 | -3,775 | 9,076 | 12,958 |
| Other Operating Activity | -139,307 | -145,223 | -39,736 | -2,310 | -3,358 |
| Operating Cash Flow | $-55,664 | $-37,368 | $-19,127 | $-82,025 | $-59,709 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -29 | N/A | -414 | -373 |
| Investing Cash Flow | $-46 | $-29 | $N/A | $-414 | $-373 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 123,552 | 123,552 | 22,160 | 2,560 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,417 |
| Financing Cash Flow | $123,552 | $123,552 | $22,160 | $2,560 | $1,417 |
| Beginning Cash Position | 121,136 | 121,136 | 121,136 | 201,015 | 201,015 |
| End Cash Position | 188,978 | 207,291 | 124,169 | 121,136 | 142,350 |
| Net Cash Flow | $67,842 | $86,155 | $3,033 | $-79,879 | $-58,665 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,664 | -37,368 | -19,127 | -82,025 | -59,709 |
| Capital Expenditure | -46 | -29 | N/A | -414 | -373 |
| Free Cash Flow | -55,710 | -37,397 | -19,127 | -82,439 | -60,082 |